Table 3.
n | Sensitivity (%) | Specificity (%) | PLR | NLR | dOR | Accuracy a | |
---|---|---|---|---|---|---|---|
PWv (>10 m/s) | |||||||
IDF criteria | 242 | 79.3 (52.7–100.0) |
59.6 (50.1–71.0) |
1.96 (0.16–24.63) |
0.35 (0.02–5.11) |
5.66 (2.21–14.48) |
0.62 (0.14–2.76) |
IDF with HbA1c criteria | 243 | 65.5 (41.8–100) |
78.5 (67.5–91.3) |
3.05 (0.23–40.48) |
0.44 (0.04–5.32) |
6.94 (3.02–15.95) |
0.77 (0.14–4.20) |
IMT (>0.8mm) | |||||||
IDF criteria | 246 | 50.0 (31.1–80.4) |
54.9 (45.8–65.8) |
1.11 (0.05–23.86) |
0.91 (0.04–18.02) |
1.22 (0.59–2.51) |
0.54 (0.13–2.20) |
IDF with HbA1c criteria | 247 | 32.4 (17.9–58.4) |
73.7 (63.0–86.2) |
1.23 (0.03–44.56) |
0.92 (0.06–15.01) |
1.34 (0.61–2.93) |
0.68 (0.13–3.37) |
ACR (>30mg/g) | |||||||
IDF criteria | 1036 | 56.9 (41.9–77.3) |
50.7 (46.4–55.4) |
1.16 (0.06–21.84) |
0.85 (0.04–17.70) |
1.36 (0.84–2.21) |
0.51 (0.13–2.02) |
IDF with HbA1c criteria | 1041 | 41.7 (29.1–59.6) |
72.7 (67.5–91.3) |
1.52 (0.06–37.55) |
0.80 (0.05–12.48) |
1.90 (1.16–3.10) |
0.71 (0.14–3.62) |
a The accuracy was defined as the number of correctly classified participants/number of all participants. PLR: positive likelihood ratio; NLR: negative likelihood ratio; dOR: diagnostic odds ratio; IDF: International Diabetes Federation; PWv: pulse wave velocity; IMT: intima media thickness; ACR: Albumin-to-creatinine ratio; HbA1c: glycated hemoglobin A1c.